skin infection

FDA Approves Durata Therapeutics' DALVANCE(TM) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Caused by Susceptible Gram-Positive Bacteria, Including MRSA, in Adults
Yahoo/Globe Newswire
Sat, 05/24/14 - 09:44 am
Durata Therapeutics
Dalvance
MRSA
skin infection
Two IPOs Brave the Markets, Two Enter the Queue: Biotech's Latest Deals
Seeking Alpha
Sun, 08/8/10 - 01:18 pm
Trius Therapeutics
Torezolid
Pfizer
linezolid
skin infection
NuPathe
Zelrix
migraines
Complete Genomics
Horizon Pharma
Trius Gets SPA From FDA For Torezolid Phosphate Phase 3 Study
Pharmaceutical Business Review
Thu, 06/17/10 - 09:53 am
Trius Therapeutics
Torezolid
skin infection
Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)
prnewschannel.com
Sun, 11/8/09 - 12:39 pm
Novexel
skin infection